|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Probiotics for antibiotic-associated diarrhea:Do we have a verdict?显示文摘Probiotics use has increased tremendously over the past ten years.This was coupled with a surge of data relating their importance in clinical practice.Antibioticassociated diarrhea,whose frequency has risen recently,was one of the earliest targets with data published more than ten years ago.Unfortunately,available trials suffer from severe discrepancies associated with variability and heterogeneity of several factors.Most published randomized controlled trials and subsequent meta-analyses suggest benefit for probiotics in the prevention of antibiotic-associated diarrhea.The same seems to also apply when the data is examined for Clostridium difficile-associated colitis.However,the largest randomized double-blind placebo-controlled trial to date examining the use of a certain preparation of probiotics in antibiotic-associated diarrhea showed disappointing results,but it was flawed with several drawbacks.The commonest species of probiotics studied across most trials is Lactobacillus;however,other types have also shown similar benefit.Probiotics have enjoyed an impeccable safety reputation.Despite a few reports of severe infections sometimes leading to septicemia,most of the available trials confirm their harmless behavior and show similaradverse events compared to placebo.Since a consensus dictating its use is still lacking,it would be advisable at this point to suggest prophylactic use of probiotics to certain patients at risk for antibiotic-associated diarrhea or to those who suffered previous episodes. | Iyad Issa Rami Moucari | 2014 | World Journal of Gastroenterology2014，20，47： | 17 |
| 2 | Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis显示文摘 | Ana-Carolina Cardoso Rami Moucari Claudio Figueiredo-Mendes Marie-Pierre Ripault Nathalie Giuily Corinne Castelnau Nathalie Boyer Tarik Asselah Michelle Martinot-Peignoux Sarah Maylin Roberto J. Carvalho-Filho Dominique Valla Pierre Bedossa Patrick Marcel | 2010 | Journal of Hepatology2010，，5： | 3 |
| 3 | Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival显示文摘瞄准:在黎巴嫩和早死亡预兆的预示的因素学习 HCC 的传染病学。方法:在一个五年的时期上诊断的 HCC 盒子的观察后续队研究被执行。Multivariate 分析被进行与肝意大利的程序(片断) 分数的癌症相比识别预示的因素。包括内在的肝疾病,病人的人口统计的特征,和孩子呸评估的肝疾病的严厉的病原学的多重变量得分被学习。肿瘤参数包括了小瘤,门静脉血栓的存在,和治疗形式的 HCC, alpha-fetoprotein 水平,数字和尺寸的诊断的时间。后续的死亡或损失被看作一个端点事件。结果:92 个病人(平均数 60.5 +/- 22.3 年) 被包括。内在的疾病的病原学分别地是在 67% , 20% ,和 23.5% 的肝炎 B, C,和酒精。在诊断的孩子呸班分别地是在 34.8% , 39.3% 和 25.8% 的 A, B,和 C。全面幸存分别地在 1, 2 和 3 年是 44.8% , 32.8% 和 17.6%( 吝啬的 F/U 40.2 +/- 23.5 瞬间) 。Multivariate 分析识别了早死亡的三个预言者(<
6 瞬间) :胆红素 >
3.2 mg/dL (P <
0.01 ) , HCC 作为肝疾病的第一个演讲(P = 0.035 ) ,并且肌酸酐 >
1 mg/dL (P = 0.017 ) 。一个分数由考克斯基于这些变量超过了片断分数比例的危险。巨鸟曲线显示了两个模型相等、中等精确。结论:HBV 是在黎巴嫩的 HCC 的领先的原因。早死亡的独立预言者是象疾病的第一表明的提高的胆红素,肌酸酐和 HCC。一个分数的未来的确认基于在预言短期的幸存的这些临床的参数被需要。 | César Yaghi Ala I Sharara Paul Rassam Rami Moucari Khalil Honein Joseph BouJaoude Rita Slim Roger Noun Heitham Abdul-Baki Mohamad Khalifeh Sami Ramia Raymond Sayegh | 2006 | World Journal of Gastroenterology2006，12，22： | 3 |
| 4 | <ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 2 |
| 5 | High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study显示文摘 | Rami Moucari Anneke Korevaar Olivier Lada Michelle Martinot-Peignoux Nathalie Boyer Vincent Mackiewicz Agnes Dauvergne Ana C. Cardoso Tarik Asselah Marie-Hélène Nicolas-Chanoine Michel Vidaud Dominique Valla Pierre Bedossa Patrick Marcellin | 2009 | Journal of Hepatology2009，，6： | 2 |
| 6 | Hepatocellular carcinoma in BuddChiari syndrome:characteristics and risk factors显示文摘 | Moucari R Rautou P E CazalsHatem D | 2008 | Gut2008，57，6： | 1 |
| 7 | Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome显示文摘 | Rautou PE Moucari R Cazals-Hatem D | 2009 | Clin Gastroenterol Hepatol2009，7，11： | 1 |
| 8 | Quantification of hepatitis B surface anti-gen:a new concept for the management of chronic hepatitis B显示文摘 | Moucari R Marcellin P | | 0，，1： | 1 |
| 9 | Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients显示文摘 | Moucari R Mackiewicz V Lada O | 2009 | Hepatology2009，49，22： | 1 |
| 10 | Sequential therapywith adefovirdipivoxil and pegylated interferon alfa - 2a forHBeAg - negative patients显示文摘 | Moucari R Boyer N Ripault MP | 2011 | J Viral Hepat2011，18，8： | 1 |
| 11 | Early serum HBsAg drop:a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients显示文摘 | Moucari R Mackiewicz V Lada O | | 0，，4： | 1 |
| 12 | Early serum HBsAg drop:A strong predictor of sustained virological response to pe-gylated interferon alfa-2a in HBeAg-negative patients显示文摘 | Moucari R Mackiewicz V Lada O | | 0，，04： | 1 |
| 13 | HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome 显示文摘 | Moucari R Marcellin P | 2010 | Gastroenterol Clin Biol2010，342，： | 1 |
| 14 | Decoupled Direct Control for PWM Inverter-fed Induction Motor Devices显示文摘 | EI Moucary Chady | 2002 | IEEE Transaction on Industry Applications2002，38，5： | 1 |
| 15 | Insulin resistance and geographical origin:major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4显示文摘 | Moucari R Ripault MP Martinot-Peignoux M | 2009 | Gut2009，58，12： | 1 |
| 16 | <ce:link locator='fx1'/> <ce:link locator='fx2'/> Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis显示文摘 | Rami Moucari Tarik Asselah Dominique Cazals–Hatem Hélène Voitot Nathalie Boyer Marie–Pierre Ripault Rodolphe Sobesky Michèle Martinot–Peignoux Sarah Maylin Marie–Hélène Nicolas–Chanoine Valérie Paradis Michel Vidaud Dominique Valla Pierre Bedossa Patrick | 2008 | Gastroenterology2008，，2： | 1 |
| 17 | Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients显示文摘 | Patrick Marcellin Ferruccio Bonino Cihan Yurdaydin Stephanos Hadziyannis Rami Moucari Hans-Peter Kapprell Vivien Rothe Matei Popescu Maurizia R. Brunetto | 2013 | Hepatology International2013，，： | 1 |
| 18 | Insulin Resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis显示文摘 | Moucari R Asselah T Cazals-Hatem D | 2008 | Gastroenterology2008，134，： | 1 |
| 19 | Insulin resistance in chronic hepatitis C:association with genotypes 1 and 4,serum HCV RNA level,and liver fibrosis显示文摘 | MOUCARI R ASSELAH T CAZALS-HATEM D | 2008 | Gastroenterology2008，134，2： | 1 |
| 20 | Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated inter- feron alfa-2a in HBeAg-negative patients 显示文摘 | Moucari R Mackiewicz V Lada O | 2009 | Hepatology2009，49，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员